Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
- PMID: 6250050
- DOI: 10.1038/286264a0
Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
Abstract
Arachidonic acid is metabolised either by cyclooxygenases to produce prostaglandins and thromboxanes or by lipoxygenases to produce mono-, di- and trihydroxyeicosatetraenoic acids (HETEs). Polymorphonuclear leukocytes (PMNs) release HETEs, including mono- and dihydroxy fatty acids, when exposed to stimuli such as the calcium ionophore A23187 (refs 1, 2). The mono-HETEs are assumed to be of particular importance with respect to effects on leukocyte function because they have been shown to possess both chemotactic and chemokinetic activities towards PMNs and eosinophils. However, we have now shown that the chemokinetic and aggregating activities released from rat and human PMNs exposed to ionophore A23187 (ref. 5) are not due to the release of mono-HETEs but to that of 5, 12-di-HETE (leukotriene B). This compound is active over the concentration range 10 pg ml-1 to 5 ng ml-1.
Similar articles
-
The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages.Prostaglandins. 1980 Dec;20(6):1007-19. doi: 10.1016/0090-6980(80)90055-6. Prostaglandins. 1980. PMID: 6259695
-
Lipoxygenase products and the polymorphonuclear leucocyte.Agents Actions. 1980 Dec;10(6):548-50. doi: 10.1007/BF02024162. Agents Actions. 1980. PMID: 6267913
-
Arachidonic acid, leukotriene B4, and neutrophil activation.Ann N Y Acad Sci. 1983;414:125-39. doi: 10.1111/j.1749-6632.1983.tb31679.x. Ann N Y Acad Sci. 1983. PMID: 6322649 Review. No abstract available.
-
Neutrophil aggregating and chemokinetic properties of a 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid isolated from human leukocytes.Prostaglandins. 1982 May;23(5):631-41. doi: 10.1016/s0090-6980(82)80003-8. Prostaglandins. 1982. PMID: 6289379
-
Leukotrienes and lipoxygenase factors: mediators and modulators of the allergic reaction.Allergol Immunopathol (Madr). 1982 Sep-Oct;10(5):385-94. Allergol Immunopathol (Madr). 1982. PMID: 6187199 Review.
Cited by
-
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial.Clin Transl Sci. 2024 Feb;17(2):e13724. doi: 10.1111/cts.13724. Clin Transl Sci. 2024. PMID: 38407540 Free PMC article. Clinical Trial.
-
Redox processes are major regulators of leukotriene synthesis in neutrophils exposed to bacteria Salmonella typhimurium; the way to manipulate neutrophil swarming.Front Immunol. 2024 Feb 7;15:1295150. doi: 10.3389/fimmu.2024.1295150. eCollection 2024. Front Immunol. 2024. PMID: 38384456 Free PMC article.
-
Quantifying neutrophil extracellular trap release in a combined infection-inflammation NET-array device.Lab Chip. 2024 Jan 30;24(3):615-628. doi: 10.1039/d3lc00648d. Lab Chip. 2024. PMID: 38189525 Free PMC article.
-
Molecular and functional changes in neutrophilic granulocytes induced by nicotine: a systematic review and critical evaluation.Front Immunol. 2023 Nov 23;14:1281685. doi: 10.3389/fimmu.2023.1281685. eCollection 2023. Front Immunol. 2023. PMID: 38077313 Free PMC article.
-
Role of Mitochondria in the Regulation of Effector Functions of Granulocytes.Cells. 2023 Sep 5;12(18):2210. doi: 10.3390/cells12182210. Cells. 2023. PMID: 37759432 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
